Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Change in Account Payables (2024 - 2026)

Prelude Therapeutics' Change in Account Payables history spans 3 years, with the latest figure at -$1.9 million for Q1 2026.

  • On a quarterly basis, Change in Account Payables rose 1.62% to -$1.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$3.9 million, a 608.77% decrease, with the full-year FY2025 number at -$3.9 million, down 218.55% from a year prior.
  • Change in Account Payables hit -$1.9 million in Q1 2026 for Prelude Therapeutics, down from $1.3 million in the prior quarter.
  • Over the last five years, Change in Account Payables for PRLD hit a ceiling of $1.8 million in Q4 2024 and a floor of -$2.4 million in Q3 2025.
  • Historically, Change in Account Payables has averaged -$276888.9 across 3 years, with a median of -$213000.0 in 2024.
  • Biggest five-year swings in Change in Account Payables: tumbled 1040.38% in 2025 and later grew 1.62% in 2026.
  • Tracing PRLD's Change in Account Payables over 3 years: stood at $1.8 million in 2024, then decreased by 29.78% to $1.3 million in 2025, then tumbled by 247.84% to -$1.9 million in 2026.
  • Business Quant data shows Change in Account Payables for PRLD at -$1.9 million in Q1 2026, $1.3 million in Q4 2025, and -$2.4 million in Q3 2025.